Central Trust Company’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.99K | Buy |
+24
| New | +$1.99K | ﹤0.01% | 1322 |
|
|
2025
Q1 | – | Sell |
-176
| Closed | -$15.9K | – | 1495 |
|
|
2024
Q4 | $15.9K | Hold |
176
| – | – | ﹤0.01% | 1007 |
|
|
2024
Q3 | $17.4K | Sell |
176
-150
| -46% | -$14.8K | ﹤0.01% | 983 |
|
|
2024
Q2 | $30.2K | Buy |
326
+150
| +85% | +$13.9K | ﹤0.01% | 871 |
|
|
2024
Q1 | $16.7K | Hold |
176
| – | – | ﹤0.01% | 989 |
|
|
2023
Q4 | $15.7K | Buy |
+176
| New | +$15.7K | ﹤0.01% | 991 |
|
|
2022
Q2 | – | Sell |
-350
| Closed | -$31K | – | 1472 |
|
|
2022
Q1 | $31K | Hold |
350
| – | – | ﹤0.01% | 884 |
|
|
2021
Q4 | $39K | Hold |
350
| – | – | ﹤0.01% | 835 |
|
|
2021
Q3 | $44K | Hold |
350
| – | – | ﹤0.01% | 788 |
|
|
2021
Q2 | $47K | Hold |
350
| – | – | ﹤0.01% | 746 |
|
|
2021
Q1 | $47K | Hold |
350
| – | – | ﹤0.01% | 709 |
|
|
2020
Q4 | $49K | Buy |
+350
| New | +$49K | ﹤0.01% | 690 |
|
|
2019
Q2 | – | Sell |
-100
| Closed | -$9K | – | 1187 |
|
|
2019
Q1 | $9K | Sell |
100
-35
| -26% | -$3.15K | ﹤0.01% | 919 |
|
|
2018
Q4 | $10K | Sell |
135
-270
| -67% | -$20K | ﹤0.01% | 902 |
|
|
2018
Q3 | $39K | Sell |
405
-15
| -4% | -$1.44K | ﹤0.01% | 725 |
|
|
2018
Q2 | $40K | Sell |
420
-190
| -31% | -$18.1K | ﹤0.01% | 708 |
|
|
2018
Q1 | $54K | Sell |
610
-105
| -15% | -$9.3K | ﹤0.01% | 676 |
|
|
2017
Q4 | $61K | Hold |
715
| – | – | ﹤0.01% | 669 |
|
|
2017
Q3 | $62K | Buy |
715
+10
| +1% | +$867 | ﹤0.01% | 646 |
|
|
2017
Q2 | $54K | Buy |
705
+570
| +422% | +$43.7K | ﹤0.01% | 679 |
|
|
2017
Q1 | $9K | Hold |
135
| – | – | ﹤0.01% | 983 |
|
|
2016
Q4 | $8K | Hold |
135
| – | – | ﹤0.01% | 1031 |
|
|
2016
Q3 | $9K | Buy |
+135
| New | +$9K | ﹤0.01% | 966 |
|